Clinical Trial Update: Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System

View source ↗

Summary

This study evaluating the Crux Vena Cava Filter System was withdrawn; no study results have been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Snippet

Sponsor: Volcano Corporation | Conditions: Pulmonary Embolism, Venous Thromboembolism | Status: WITHDRAWN